Remdesivir, made by U.S.-based Gilead Sciences Inc, has been in high
demand globally, and a handful of companies including Cipla are
authorised to make and sell generic versions in 127 developing
nations.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-shortage-of-remdesivir-is-easing-to-ramp-up-production-producer-cipla/articleshow/77487763.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment